PRETORIA (Reuters) – South Africa’s competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency’s chief said on Tuesday.
About the author
← Western Digital seeks court injunction to block sale of Toshiba chip unit Cubans fret new Trump policy will dampen tourism boom →
May 24, 2017 Comments Off on Ethiopia’s Tedros wins WHO race, first African to get top job
January 28, 2017 Comments Off on South African artist shapes salt into famous faces
December 12, 2016 Comments Off on BREAKING: Millions Of Confirmed African Migrants Have Now Been Smuggled Into…